[시장보고서]생물학적 안전성 시험 제품 및 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측

생물학적 안전성 시험 제품 및 서비스 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 용도별, 시험 유형별, 지역별, 경쟁별(2020-2030년)

Biological Safety Testing Products and Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Test Type, By Region and Competition, 2020-2030F

상품코드 : 1881435

리서치사 : TechSci Research

발행일 : 2025년 11월

페이지 정보 : 영문 185 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,681,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 8,165,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,877,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 생물학적 안전성 시험 제품 및 서비스 시장은 2024년에 47억 7,000만 달러로 평가되었으며, 2030년까지 CAGR 9.32%로 성장하여 81억 4,000만 달러에 달할 것으로 예측됩니다.

세계 생물학적 안전성 시험 제품 및 서비스 시장은 백신, 유전자 치료제, 바이오의약품 등 생물학적 제품의 순도, 유효성, 안전성을 개발 및 제조 라이프사이클 전반에 걸쳐 보장하는 데 필수적인 분석, 시약, 기기, 위탁시험 서비스를 포함합니다. 시장 성장은 주로 첨단 치료법의 복잡성 증가, 바이오의약품 승인에 대한 엄격한 세계 규제 요건, 신규 생물학적 제제 및 바이오시밀러 파이프라인의 확대에 의해 주도되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	47억 7,000만 달러
시장 규모 : 2030년	81억 4,000만 달러
CAGR : 2025-2030년	9.32%
가장 빠르게 성장하는 부문	시약·키트
최대 시장	북미

주요 시장 촉진요인

세포 치료제 및 유전자 치료제 파이프라인의 확대와 생물학적 제제에 대한 엄격한 세계 규제 요건은 세계 생물학적 안전성 시험 제품 및 서비스 시장의 두 가지 중요한 촉진요인입니다. 특히 세포 치료나 유전자 치료와 같은 새로운 첨단 치료법이 빠르게 보급됨에 따라, 개발 및 제조의 모든 단계에서 광범위하고 전문적인 안전성 평가가 필수적으로 요구되고 있습니다.

주요 시장 과제

첨단 시험 인프라 구축 및 유지에 필요한 막대한 자본 투자는 세계 생물학적 안전성 시험 제품 및 서비스 시장의 성장에 큰 장벽으로 작용하고 있습니다. 이러한 재정적 장벽은 신규 서비스 제공업체의 시장 진입을 제한하고, 기존 기업의 역량 확대와 최신 기술로의 업그레이드를 방해하고 있습니다.

주요 시장 동향

세계 생물학적 안전성 시험 제품 및 서비스 시장은 신속하고 처리량이 높은 시험 기술의 발전에 의해 크게 형성되고 있습니다. 이러한 혁신은 개발 기간 단축과 생물학적 제품 안전성 평가의 효율성 향상을 위한 업계의 중요한 요구에 부응하는 것입니다.

시장 규모 및 예측
- 금액별
시장 점유율과 예측
- 제품별(시약·키트, 서비스, 기기)
- 용도별(백신·치료제, 유전자 치료, 단클론항체, 재조합 단백질, 혈액·혈액 유래 제품, 조직·조직 유래 제품, 줄기세포)
- 시험 종별(엔도톡신 시험, 무균 시험, 세포주 인증·특성 평가 시험, 바이오버든 시험, 외래 이물 검출 시험, 잔류 숙주 오염 검출 시험, 기타)
- 지역별
- 기업별(2024)
시장 맵

제6장 북미의 생물학적 안전성 시험 제품 및 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 생물학적 안전성 시험 제품 및 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 생물학적 안전성 시험 제품 및 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 중동 및 아프리카의 생물학적 안전성 시험 제품 및 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
- 사우디아라비아
- 아랍에미리트
- 남아프리카공화국

제10장 남미의 생물학적 안전성 시험 제품 및 서비스 시장 전망

시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
- 브라질
- 콜롬비아
- 아르헨티나

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

인수합병
제품 출시
최근 동향

제13장 세계의 생물학적 안전성 시험 제품 및 서비스 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협

제15장 경쟁 구도

Charles River Laboratories International, Inc.
BSL Bioservice Scientific Laboratories Munich GmbH
Merck KGaA
Samsung Biologics
Sartorius AG
Eurofins Scientific(Ireland) Limited
SGS Societe Generale de Surveillance SA
Thermo Fisher Scientific Inc.
BIOMERIEUX SA
Lonza Group Ltd.

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM

영문 목차

영문목차

The Global Biological Safety Testing Products and Services Market, valued at USD 4.77 Billion in 2024, is projected to experience a CAGR of 9.32% to reach USD 8.14 Billion by 2030. The Global Biological Safety Testing Products and Services Market encompasses assays, reagents, instruments, and contract testing services crucial for ensuring the purity, potency, and safety of biological products such as vaccines, gene therapies, and biopharmaceuticals throughout their development and manufacturing lifecycle. The market's growth is primarily driven by the increasing complexity of advanced therapeutic modalities, stringent global regulatory mandates for biopharmaceutical approval, and the expanding pipeline of new biologics and biosimilars.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 4.77 Billion
Market Size 2030	USD 8.14 Billion
CAGR 2025-2030	9.32%
Fastest Growing Segment	Reagents & Kits
Largest Market	North America

Key Market Drivers

The expanding pipeline of cell and gene therapies and stringent global regulatory requirements for biologics represent two pivotal drivers for the Global Biological Safety Testing Products and Services Market. The increasing proliferation of novel advanced therapeutic modalities, particularly cell and gene therapies, inherently demands extensive and specialized safety assessments throughout their development and manufacturing. These therapies involve complex biological constructs that necessitate rigorous testing to ensure product purity, potency, and freedom from adventitious agents. According to the Alliance for Regenerative Medicine's annual Cell & Gene State of the Industry Briefing, in January 2024, seven cell and gene therapies received FDA approval in the U. S. in 2023, with predictions for up to 17 approvals in the U.S. and EU in 2024.

Key Market Challenges

The substantial capital expenditure required for establishing and maintaining advanced testing infrastructure presents a significant impediment to the growth of the Global Biological Safety Testing Products and Services Market. This financial barrier limits the ability of new service providers to enter the market and hinders existing firms from expanding their capabilities or upgrading to the latest technologies. Developing and equipping laboratories with advanced assays, reagents, and instruments for complex biological product analysis demands considerable upfront investment, directly constraining the overall capacity available to meet increasing industry demand for safety assessments.

Key Market Trends

The Global Biological Safety Testing Products and Services Market is significantly shaped by advancements in rapid and high-throughput testing technologies. These innovations address the critical industry need for accelerated development timelines and increased efficiency in assessing biological product safety. The integration of advanced platforms, such as next-generation sequencing and automated systems, allows for faster detection of contaminants and more comprehensive characterization of complex biologics.

Key Market Players

Charles River Laboratories International, Inc.
BSL Bioservice Scientific Laboratories Munich GmbH
Merck KGaA
Samsung Biologics
Sartorius AG
Eurofins Scientific (Ireland) Limited
SGS Societe Generale de Surveillance SA
Thermo Fisher Scientific Inc.
BIOMERIEUX SA
Lonza Group Ltd.

Report Scope:

In this report, the Global Biological Safety Testing Products and Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Safety Testing Products and Services Market, By Product:

Reagents & Kits
Services
Instruments

Biological Safety Testing Products and Services Market, By Application:

Vaccines & Therapeutics
Gene Therapy
Monoclonal Antibodies
Recombinant Protein
Blood & Blood-based Products
Tissue & Tissue-based Products
Stem Cells

Biological Safety Testing Products and Services Market, By Test Type:

Endotoxin Tests
Sterility Tests
Cell Line Authentication & Characterization Tests
Bioburden Tests
Adventitious Agent Detection Tests
Residual Host Contamination Detection Tests
Others

Biological Safety Testing Products and Services Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Safety Testing Products and Services Market.

Available Customizations:

Global Biological Safety Testing Products and Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Safety Testing Products and Services Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Product (Reagents & Kits, Services, Instruments)
- 5.2.2. By Application (Vaccines & Therapeutics, Gene Therapy, Monoclonal Antibodies, Recombinant Protein, Blood & Blood-based Products, Tissue & Tissue-based Products, Stem Cells)
- 5.2.3. By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Others)
- 5.2.4. By Region
- 5.2.5. By Company (2024)
5.3. Market Map

6. North America Biological Safety Testing Products and Services Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Application
- 6.2.3. By Test Type
- 6.2.4. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Biological Safety Testing Products and Services Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Product
    - 6.3.1.2.2. By Application
    - 6.3.1.2.3. By Test Type
- 6.3.2. Canada Biological Safety Testing Products and Services Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Product
    - 6.3.2.2.2. By Application
    - 6.3.2.2.3. By Test Type
- 6.3.3. Mexico Biological Safety Testing Products and Services Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Product
    - 6.3.3.2.2. By Application
    - 6.3.3.2.3. By Test Type

7. Europe Biological Safety Testing Products and Services Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Application
- 7.2.3. By Test Type
- 7.2.4. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Biological Safety Testing Products and Services Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Product
    - 7.3.1.2.2. By Application
    - 7.3.1.2.3. By Test Type
- 7.3.2. France Biological Safety Testing Products and Services Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Product
    - 7.3.2.2.2. By Application
    - 7.3.2.2.3. By Test Type
- 7.3.3. United Kingdom Biological Safety Testing Products and Services Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Product
    - 7.3.3.2.2. By Application
    - 7.3.3.2.3. By Test Type
- 7.3.4. Italy Biological Safety Testing Products and Services Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Product
    - 7.3.4.2.2. By Application
    - 7.3.4.2.3. By Test Type
- 7.3.5. Spain Biological Safety Testing Products and Services Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Product
    - 7.3.5.2.2. By Application
    - 7.3.5.2.3. By Test Type

8. Asia Pacific Biological Safety Testing Products and Services Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Product
- 8.2.2. By Application
- 8.2.3. By Test Type
- 8.2.4. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Biological Safety Testing Products and Services Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Product
    - 8.3.1.2.2. By Application
    - 8.3.1.2.3. By Test Type
- 8.3.2. India Biological Safety Testing Products and Services Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Product
    - 8.3.2.2.2. By Application
    - 8.3.2.2.3. By Test Type
- 8.3.3. Japan Biological Safety Testing Products and Services Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Product
    - 8.3.3.2.2. By Application
    - 8.3.3.2.3. By Test Type
- 8.3.4. South Korea Biological Safety Testing Products and Services Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Product
    - 8.3.4.2.2. By Application
    - 8.3.4.2.3. By Test Type
- 8.3.5. Australia Biological Safety Testing Products and Services Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Product
    - 8.3.5.2.2. By Application
    - 8.3.5.2.3. By Test Type

9. Middle East & Africa Biological Safety Testing Products and Services Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Application
- 9.2.3. By Test Type
- 9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Biological Safety Testing Products and Services Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Product
    - 9.3.1.2.2. By Application
    - 9.3.1.2.3. By Test Type
- 9.3.2. UAE Biological Safety Testing Products and Services Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Product
    - 9.3.2.2.2. By Application
    - 9.3.2.2.3. By Test Type
- 9.3.3. South Africa Biological Safety Testing Products and Services Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Product
    - 9.3.3.2.2. By Application
    - 9.3.3.2.3. By Test Type

10. South America Biological Safety Testing Products and Services Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Product
- 10.2.2. By Application
- 10.2.3. By Test Type
- 10.2.4. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Biological Safety Testing Products and Services Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Product
    - 10.3.1.2.2. By Application
    - 10.3.1.2.3. By Test Type
- 10.3.2. Colombia Biological Safety Testing Products and Services Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Product
    - 10.3.2.2.2. By Application
    - 10.3.2.2.3. By Test Type
- 10.3.3. Argentina Biological Safety Testing Products and Services Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Product
    - 10.3.3.2.2. By Application
    - 10.3.3.2.3. By Test Type

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Biological Safety Testing Products and Services Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Charles River Laboratories International, Inc.
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. BSL Bioservice Scientific Laboratories Munich GmbH
15.3. Merck KGaA
15.4. Samsung Biologics
15.5. Sartorius AG
15.6. Eurofins Scientific (Ireland) Limited
15.7. SGS Societe Generale de Surveillance SA
15.8. Thermo Fisher Scientific Inc.
15.9. BIOMERIEUX SA
15.10. Lonza Group Ltd.